Clinical and Molecular Characterization of a RASopathy Cohort From Türkiye and an AMMECR1 ‐Related Noonan Syndrome‐Mimicking Phenotype
Clinical Genetics · 2026
DOI: 10.1111/cge.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Esma Nur Konur Akbaş und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Noonan Syndrome, ras Proteins, Neurofibromatosis 1, Failure to Thrive. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Istanbul University Scientific Research Projects Unit.
Abstract (Originalsprache)
RASopathies comprise a group of congenital malformation syndromes with predominant neuro‐cardio‐facial‐cutaneous involvement resulting from pathogenic variants in RAS/mitogen‐activated protein kinase (MAPK) signaling pathway genes. In this study 33 patients are presented with their clinical and molecular findings as an RASopathy cohort including a family with an AMMECR1 ‐related disorder. The diagnostic distribution of the cohort included Noonan syndrome ( n = 18), neurofibromatosis type 1 ( n = 8), and single cases of cardiofaciocutaneous syndrome, Costello syndrome, neurofibromatosis‐Noonan syndrome, NF1 microdeletion syndrome, Noonan syndrome‐like disorder with loose anagen hair, Noonan syndrome with multiple lentigines and AMMECR1 ‐related midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MIM# 300990). The most prevalent clinical manifestations were dermatological findings (90.9%), skeletal features (84.4%), cardiovascular involvement (75.8%), and typical craniofacial dysmorphism suggestive of RASopathy (72.7%). Variants were most frequently identified in PTPN11 and NF1 , followed by single cases involving the BRAF , HRAS , LZTR1 , RAF1 , RIT1 , SHOC2 , and SOS1 . Notably, one patient harbored a variant in AMMECR1 , which is not involved in the RAS/MAPK pathway. Overall, this study delineates the clinical and molecular landscape of a cohort from Türkiye and underscores that the AMMECR1 ‐related phenotype represents a distinct entity that closely mimics Noonan syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Medical Genetics, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
- Department of Medical Genetics, School of Medicine, Koc University, KUSOM, Istanbul, Turkey.
- Department of Medical Genetics, Faculty of Medicine, Istanbul Atlas University, Istanbul, Turkey.
ORCID-Profile: Esma Nur Konur Akbaş, Güven Toksoy, Şahin Avcı, Umut Altunoğlu, Gözde Yeşil Sayın, Zehra Oya Uyguner, Ayça Dilruba Aslanger
Förderung
- Istanbul University Scientific Research Projects Unit
Zitieren
APA
Akbaş, E. N. K., Toksoy, G., Avcı, Ş., Altunoğlu, U., Kalaycı, T., Sayın, G. Y., Kayserili, H., Uyguner, Z. O., & Aslanger, A. D. (2026). Clinical and Molecular Characterization of a RASopathy Cohort From Türkiye and an AMMECR1 ‐Related Noonan Syndrome‐Mimicking Phenotype. Clinical Genetics. https://doi.org/10.1111/cge.70217
Vancouver
Akbaş ENK, Toksoy G, Avcı Ş, Altunoğlu U, Kalaycı T, Sayın GY, et al. Clinical and Molecular Characterization of a RASopathy Cohort From Türkiye and an AMMECR1 ‐Related Noonan Syndrome‐Mimicking Phenotype. Clinical Genetics. 2026. doi:10.1111/cge.70217
BibTeX
@article{Akba2026,
author = {Akbaş, Esma Nur Konur and Toksoy, Güven and Avcı, Şahin and Altunoğlu, Umut and Kalaycı, Tuğba and Sayın, Gözde Yeşil and Kayserili, Hülya and Uyguner, Zehra Oya and Aslanger, Ayça Dilruba},
title = {Clinical and Molecular Characterization of a RASopathy Cohort From Türkiye and an AMMECR1 ‐Related Noonan Syndrome‐Mimicking Phenotype},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70217}
}
EUVIMED